OncoSec Medical to Present at the Second Annual Marcum LLP MicroCap Conference

OncoSec Medical to Present at the Second Annual Marcum LLP MicroCap Conference

22 May 2013,   By ,   0 Comments

SAN DIEGO – May 21, 2013 – OncoSec Medical Inc. (OTCBQ: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Punit Dhillon, President and CEO, will present at the Second Annual Marcum LLP MicroCap Conference at the Grand Hyatt Hotel in New York City on Thursday, May 30 at 9:00 AM ET.

 

About Marcum LLP MicroCap Conference

This invitation-only event attracts institutional investors including top fund managers and qualified high net worth investors, who focus on small cap equities. This year, the conference is expected to draw more than 1,000 attendees including senior personnel from over 100 presenting public companies.

 

 


Real Time Web Analytics